Although the concentrations of TNF-α were higher in the active untreated AOSD patients when compared to healthy donors [43], canakinumab showed no effect on the concentrations of TNF cytokines used in this study (TNF-α and BAFF). The gene discussed is TNF; the disease is adult-onset Still disease.